ÂÜÀòÂÒÂ×

Partha Ghosh is an experienced professional in the field of regulatory CMC and pharmaceutical development. Currently serving as the Director of Regulatory CMC at Viridian Therapeutics, Inc. since 2021, Ghosh previously held the position of CMC Lead at NOVAVAX INC from 2020 to 2021. Prior roles include Pharmaceutical Development Scientist II at GlycoMimetics from 2015 to 2020, Post-Doctoral Scientist at Boston Biomedical, Inc. in 2014-2015, and several post-doctoral positions at prestigious institutions such as the Massachusetts Institute of Technology, Harvard Medical School/Massachusetts General Hospital, and Yale University, spanning from 2009 to 2014. Ghosh holds a PhD in Chemistry from the University of Massachusetts Amherst, a Master of Science in Chemistry from the Indian Institute of Technology, Kanpur, and a Bachelor of Science in Chemistry from Ramakrishna Mission Vidyamandira Belur.